Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Why the obesity drug market is about to get a lot more crowded
Medical Marketing and Media
Fri, 04/26/24 - 11:49 am
obesity
Novo Nordisk
Wegovy
Eli Lilly
Zepbound
Roche
AstraZeneca
As Lilly and BMS invest in manufacturing, demand for drugs still outweighs supply
Pharma Voice
Fri, 04/26/24 - 11:47 am
drug shortages
drug manufacturing
Eli Lilly
Bristol Myers Squibb
Endeavor pulls in $132M to back cancer, lung disease drugs
BioPharma Dive
Wed, 04/24/24 - 08:45 am
Endeavor BioMedicines
funding
IPF
Eli Lilly
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market
Motley Fool
Wed, 04/24/24 - 08:43 am
Eli Lilly
weight loss
Zepbound
Big Pharma market caps surge to start 2024 despite economic headwinds
Medical Marketing and Media
Tue, 04/23/24 - 10:38 am
Big Pharma
market cap
Novo Nordisk
Eli Lilly
Lilly to buy injectable drug plant in manufacturing ramp-up
BioPharma Dive
Mon, 04/22/24 - 05:54 pm
Eli Lilly
drug manufacturing
Mounjaro
Zepbound
Wisconsin
Roche’s Early Alzheimer’s Blood Test Gets FDA Breakthrough Device Designation
Xtalks
Thu, 04/18/24 - 10:28 pm
Roche
FDA
Medtech
Eli Lilly
Elecsys pTau217
Alzheimer's disease
diagnostics
Drugs Like Ozempic And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are Looking At
Forbes
Thu, 04/18/24 - 10:25 pm
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Zepbound
Mounjaro
anxiety
addiction
heart disease
liver disease
Lilly Alzheimer's med glides out of Leqembi's slipstream with FDA adcomm request
Fierce Biotech
Wed, 04/17/24 - 09:58 pm
Eli Lilly
donanemab
Alzheimer's disease
Leqembi
Biogen
Eisai
FDA
Lilly eyes Zepbound label expansion after clearing phase III sleep apnea study
BioSpace
Wed, 04/17/24 - 11:32 am
Eli Lilly
Zepbound
sleep apnea
Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says
Reuters
Wed, 04/17/24 - 11:21 am
drug shortages
Eli Lilly
Zepbound
Mounjaro
diabetes
weight loss
Lilly's Prevail walks away from gene editing collab with Precision
Fierce Biotech
Wed, 04/17/24 - 11:11 am
Eli Lilly
Prevail Therapeutics
gene editing
Precision Biosciences
Eli Lilly's nationwide insulin pricing settlement called off
Reuters
Mon, 04/15/24 - 09:28 pm
Eli Lilly
insulin
diabetes
drug pricing
legal
4 Investigational Weight Loss Drugs That Could Change the Market
BioSpace
Mon, 04/15/24 - 11:09 am
weight loss
Novo Nordisk
CagriSema
Eli Lilly
orforglipro
Viking Therapeutics
VK-2735
Inversago Pharma
INV-202
Lilly Suffers Legal Loss in Tirzepatide Case Against Compounding Pharmacy
BioSpace
Fri, 04/12/24 - 11:13 am
Eli Lilly
tirzepatide
legal
compounding pharmacies
FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test
Pharmaphorum
Thu, 04/11/24 - 10:52 am
diagnostics
Roche
Eli Lilly
Alzheimer's disease
FDA
breakthrough designation
EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk
BioSpace
Tue, 04/9/24 - 11:11 am
EMA
Europe
diabetes
weight loss
Novo Nordisk
Ozempic
Wegovy
Eli Lilly
Trulicity
Saxenda
Rybelsus
Victoza
Jardiance doesn’t cut it in post-heart attack trial
Pharmaphorum
Mon, 04/8/24 - 11:21 am
Boehringer Ingelheim
Eli Lilly
Jardiance
clinical trials
heart attack
Eli Lilly's popular diabetes drug Mounjaro to face continued supply squeeze through April, FDA says
Fierce Pharma
Tue, 04/2/24 - 10:03 pm
Eli Lilly
Mounjaro
drug shortages
diabetes
Ozempic-like drugs linked to low, but increased risk of post-endoscopy pneumonia, study finds
Stat
Thu, 03/28/24 - 11:19 am
Ozempic
obesity
diabetes
Novo Nordisk
aspiration pneumonia
Eli Lilly
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »